Tislelizumab

ATC L01FF09 · 10 markets · 15 records

Tislelizumab 10 markets · 15 records Forms

US 3 records · 1 strengths

10 mginjectionTEVIMBRA+1Manufacturer: Novartis Pharma Stein AG

AU 3 records · 3 strengths

100 mg/10 mLinjectionTEVIMBRA also in GB·SG·CN
100 mginjectionTEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial also in ES unknown

Records without a stated strength · 1 TEVIMBRA

GB 1 records · 1 strengths

100 mg/10 mLinjectionTevimbra 100mg/10ml concentrate for solution for infusion vials also in AU·SG·CN

CA 1 records · 1 strengths

10 mg/1 mLliquidTEVIMBRA

SG 1 records · 1 strengths

100 mg/10 mLinjectionTEVIMBRA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML also in AU·GB·CN

CN 1 records · 1 strengths

100 mg/10 mLinjection百泽安替雷利珠单抗 also in AU·GB·SG

ES 1 records · 1 strengths

100 mginjectionTEVIMBRA also in AU

TW 1 records · 1 strengths

Records without a stated strength · 1 Tevimbra Concentrated Solution for Infusion、汰瘤安注射劑

HK 1 records · 1 strengths

Records without a stated strength · 1 TEVIMBRA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 TEVIMBRA

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU
100 mg/10 mL injection	not recorded	Tevimbra 100mg/10ml concentrate for solution for infusion vials	not recorded	TEVIMBRA	TEVIMBRA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML	百泽安替雷利珠单抗	not recorded	not recorded	not recorded	not recorded
100 mg injection	not recorded	not recorded	not recorded	TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial	not recorded	not recorded	TEVIMBRA	not recorded	not recorded	not recorded
10 mg injection	Manufacturer: Novartis Pharma Stein AG TEVIMBRA	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
10 mg/1 mL liquid	not recorded	not recorded	TEVIMBRA	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	TEVIMBRA	not recorded	not recorded	not recorded	not recorded	TEVIMBRA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML	TEVIMBRA
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Tevimbra Concentrated Solution for Infusion 汰瘤安注射劑	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录（未在本表显示）。另有 1 個規格/劑型僅在 CA 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.